Medindia

X

Alfred Mann Foundation for Biomedical Engineering Launches New Web Site Designed to Help University Researchers Bring Biomedical Advances to Market

Wednesday, December 3, 2008 General News J E 4
Advertisement
VALENCIA, Calif., Dec. 2 The Alfred E. Mann Foundation forBiomedical Engineering (AEMFBE), a philanthropic organization created bybillionaire Alfred E. Mann to establish university-based commercialization-enablement institutes at elite universities, designed to facilitate biomedicalproduct development for the benefit of society, today announced the launch ofa Web site (http://www.mannfbe.org).

Features of the web site include:

-- Overview of Alfred Mann Institutes for Biomedical Development (AMIs),including the infrastructure and process that are created by the minimum of$100 million endowment to establish each Institute. To date, three AlfredMann Institutes have been endowed: University of Southern California (LosAngeles), which became operational in 2001 as a test-bed for the developmentfor future AMIs; the Technion (Haifa, Israel), 2007; and Purdue University(West Lafayette, Indiana.), 2008.

-- Background and accomplishments of Mr. Mann, who has dedicated most ofhis career to bettering the quality of life for those who suffer from lifedebilitating disorders through the development of innovative medical devices.

-- "Commercialize Your Idea," which provides insight into thedevelopmental steps for a biomedical technology including proof of concept,FDA regulatory approval, reimbursement strategies, technology licensingconsiderations, etc., with an emphasis toward researchers involved in thisspace.

"The AMI concept has drawn a phenomenal response, both nationally andinternationally, as a new model for technology transfer, a form of venturephilanthropy," said A. Stephen Dahms, Ph.D., President and CEO of the AEMFBE."The Web site addresses researchers' frequently asked questions and providesan overview of the AMI selection and creation process."

About Alfred Mann

Alfred Mann's philanthropic mission is to create and expedite the deliveryof life-improving biomedical products to patients. Mann is chairman of theboards of directors for the Alfred Mann Institutes for Biomedical Developmentat USC, Purdue and the Technion. Mann also is chairman and chief executiveofficer of MannKind Corp.; chairman of Advanced Bionics Corp, Second Sight LLC,Bioness Inc., Quallion LLC and Implanted Acoustics; and chairman emeritus ofPacesetter System Inc. and MiniMed. All of these highly successful companieswere founded by Mann.

About the Mann Foundation for Biomedical Engineering

Headquartered in the 167-acre Mann Biomedical Park in Valencia, Calif.,the Alfred Mann Foundation for Biomedical Engineering (AEMFBE) is aphilanthropic organization that establishes university-based institutes (AMIs)designed to enable biomedical product development for the benefit of mankind.The AEMFBE supports the AMIs with a variety of services, including marketanalysis and due diligence, valuation and exit strategy, regulatory andreimbursement guidance, cost of goods analysis and other product developmentactivities required to expedite technologies from development tocommercialization.Contact: Nancy Patterson Vice President 626-993-4106 Nancy.patterson@mannfbe.org

SOURCE Alfred E. Mann Foundation for Biomedical Engineering
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
New Sun Shower(TM) Super Blends: Iced Coffees, Tea...
S
Bon Secours, Sentara to Collaborate on Princess An...